Literature DB >> 2334816

Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes.

A Stephanou1, D S Jessop, R A Knight, S L Lightman.   

Abstract

Unstimulated normal leukocytes were studied for their expression of corticotrophin-releasing factor (CRF)-like mRNA and peptide. In situ hybridization demonstrated CRF mRNA in T and B lymphocytes and in neutrophils. Northern blot analysis also detected the presence of a CRF mRNA species of approximately 1.7 Kb from lymphocytes and a peptide that reacted with anti-CRF antiserum was also detected by radioimmunoassay. This lymphocyte-derived peptide eluted earlier than standard CRF on high performance liquid chromatography. These findings suggest that regulatory mechanisms within the hypothalamus and the immune system may utilize closely related peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334816     DOI: 10.1016/0889-1591(90)90007-d

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  22 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Immunoreactive growth hormone production by human lymphocyte cell lines.

Authors:  T L Kao; S C Supowit; E A Thompson; W J Meyer
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

3.  Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.

Authors:  Eric M Smith
Journal:  Brain Behav Immun       Date:  2007-09-27       Impact factor: 7.217

Review 4.  Brain behavior and immunity: twenty years of T cells.

Authors:  Jan A Moynihan; Félix M Santiago
Journal:  Brain Behav Immun       Date:  2007-08-02       Impact factor: 7.217

5.  Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.

Authors:  G Cantarella; L Lempereur; G Lombardo; A Chiarenza; C Pafumi; G Zappalà; R Bernardini
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Corticotropin-releasing hormone regulates IL-6 expression during inflammation.

Authors:  M Venihaki; P Dikkes; A Carrigan; K P Karalis
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

7.  Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells.

Authors:  L J Muglia; N A Jenkins; D J Gilbert; N G Copeland; J A Majzoub
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 8.  A review of metabolic staging in severely injured patients.

Authors:  Maria-Angeles Aller; Jose-Ignacio Arias; Alfredo Alonso-Poza; Jaime Arias
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-05-17       Impact factor: 2.953

9.  Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.

Authors:  G Mastorakos; E L Webster; T C Friedman; G P Chrousos
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 10.  Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach.

Authors:  Nadja Tariverdian; Theoharis C Theoharides; Friederike Siedentopf; Gabriela Gutiérrez; Udo Jeschke; Gabriel A Rabinovich; Sandra M Blois; Petra C Arck
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.